Emory researchers' LASIK PMA is approvable, but more data needed -- FDA panel.
This article was originally published in The Gray Sheet
Executive Summary
EMORY LASIK PMA IS APPROVABLE, BUT NEEDS TO RETURN TO PANEL with further data analysis and additional data from an ongoing Group 2 trial, FDA's Ophthalmic Devices Panel concluded at a July 11 meeting in Gaithersburg, Maryland.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.